You are here: Home » Companies » News
Boeing says its Super Hornet fighter makes economic and operational sense
Business Standard

Lupin gets USFDA approval for Formoterol Fumarate Inhalation Solution

The company has received approval from the USFA for the product which is a generic version of Mylan Specialty's Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement

Topics
Lupin | USFDA | generic medicines

Press Trust of India  |  New Delhi 



Lupin
As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market.

on Wednesday said it has received approval from the for Formoterol Fumarate Inhalation Solution, used in treating symptoms of chronic obstructive pulmonary disease.

The company has received approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of Mylan Specialty's Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement.

As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market.

Shares of ended 2.55 per cent down at Rs 677.65 apiece on the BSE on Wednesday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, August 24 2022. 21:34 IST

RECOMMENDED FOR YOU

.